The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement
- PMID: 35115178
- DOI: 10.1016/j.maturitas.2021.12.001
The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement
Abstract
Introduction: The menopause, or the cessation of menstruation, is a stage of the life cycle which will occur in all women. Managing perimenopausal and postmenopausal health is a key issue for all areas of healthcare, not just gynecology.
Aim: To provide recommendations for the curriculum of education programs for healthcare professionals worldwide, so that all can receive high quality training on menopause.
Materials and methods: Literature review and consensus of expert opinion.
Summary recommendations: Training programs for healthcare professionals worldwide should include menopause and postmenopausal health in their curriculum. It should include assessment, diagnosis and evidence-based management strategies.
Keywords: Cardiovascular disease; Dementia; Education; Menopause; Osteoporosis; Premature ovarian insufficiency; Women's health.
Copyright © 2021. Published by Elsevier B.V.
Conflict of interest statement
Margaret Rees has received consulting fees in the past 3 years from Sojournix, Inc. Kathy Abernethy: None declared Gloria Bachmann: None declared Silvia Bretz: None declared Iuliana Ceausu: None declared. Fatih Durmusoglu: None declared. Risto Erkkola: None declared. Ivan Fistonic: has received consulting fees in the past 3 years from Fotona Inc. Marco Gambacciani: has received speaker and consulting fees in the past 3 years from MSD, Theramex and Bayer Marije Geukes: None declared Dimitrios G. Goulis: None declared. Amanda Griffiths: None declared Haitham Hamoda: None declared Claire Hardy: is director of the workplace consultancy company Hardy People Ltd. Caiomhe Hartley: None declared Angelica Lindén Hirschberg in the past 3 years has received grant support from ITF Research Pharma for the "Blissafe study" Angela Kydd: None declared Skye Marshall: None declared Blazej Meczekalski: None declared Nicolas Mendoza in the past 3 years has received grant support from Astellas Pharma. Alfred Mueck: None declared Emma Persand: None declared Kathleen Riach: None declared Antonina Smetnik: none declared Petra Stute has received speaker and consulting fees in the past 3 years from Besins Healthcare, Jenapharm GmbH & Co. KG, Labatec Pharma SA, Effik SA, Astellas Pharma AG and Viatris Mick van Trotsenburg: None declared. Nese Yuksel has received speaker and/or advisory board fees in the past 3 years from Biosyent, Pfizer and Amgen. Rachel Weiss is the chair of Menopause Café® www.menopausecafe.net. Irene Lambrinoudaki: None declared.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
